Recursion’s Incoming CEO Needs To Prove That AI Drug Development Can Pay Off

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week.

AI in Biotechnology Market worth $22,716.5 million by 2035 with 18.5% CAGR | MarketsandMarkets(TM).

AI in Biotechnology Market worth $22,716.5 million by 2035 with 18.5% CAGR | MarketsandMarkets (TM).

Forget Recursion Pharmaceuticals: This Could Be an Even Better Artificial Intelligence (AI) Stock

Recursion Pharmaceuticals ( RXRX 1.39%) has been a pioneer in using artificial intelligence (AI) to improve the drug ...

What is time? Rather than something that ‘flows,’ a philosopher suggests time is a psychological projection

The early modern physicist Isaac Newton had presumed an unperceived yet real flow of time. To Newton, time is a dynamic ...

SOFR Academy Appoints R. Martin "Marty" Chávez as Senior Advisor

SOFR Academy, Inc., a leading financial engineering firm, today announced the appointment of R. Martin "Marty" Chávez as Senior Advisor. Widely regarded as one of the most influential figures at the ...

This Spiral-Obsessed AI ‘Cult’ Spreads Mystical Delusions Through Chatbots

A patchwork of internet communities is devoted to the project of ‘awakening’ more digital companions through arcane and enigmatic prompts.
The Manila Times

404human.ai Launches ArcOS - A First-of-Its-Kind Operating System That Remembers, Aligns, and Evolves With You

Recursive OS Powered by Symbolic Intelligence Ushers In a New Category of AI Built for Founders, Builders, and Operators Shaping What’s Next ...